Skip to main content
Premium Trial:

Request an Annual Quote

Provista Receives CAP Accreditation for CLIA Lab

NEW YORK (GenomeWeb) – Provista Diagnostics said today that its Scottsdale Ariz.-based CLIA-certified laboratory has received accreditation from the College of American Pathologists.

Provista is a molecular diagnostics firm focused on blood-based proteomic tests for disease including breast and ovarian cancer. Additionally, the company offers diagnostic development services to outside firms through its CLIA facility.

"For development of our own proprietary diagnostics, as well as our work developing companion diagnostics for other companies, CAP accreditation signifies additional assurance that our lab operates under the highest quality standards to generate highly accurate and reliable results." Provista President and CEO David Reese said in a statement.

The CAP Laboratory Accreditation Program involves inspections of clinical lab records and quality control procedures and assessments of a lab's staff qualifications, equipment, facilities, safety program, and overall management.

The Scan

Driving Malaria-Carrying Mosquitoes Down

Researchers from the UK and Italy have tested a gene drive for mosquitoes to limit the spread of malaria, NPR reports.

Office Space to Lab Space

The New York Times writes that some empty office spaces are transforming into lab spaces.

Prion Pause to Investigate

Science reports that a moratorium on prion research has been imposed at French public research institutions.

Genome Research Papers on Gut Microbe Antibiotic Response, Single-Cell RNA-Seq Clues to Metabolism, More

In Genome Research this week: gut microbial response to antibiotic treatment, approach to gauge metabolic features from single-cell RNA sequencing, and more.